Litigation Details for MYLAN SPECIALTY L.P. v. AUROBINDO PHARMA USA INC. (D.N.J. 2018)
✉ Email this page to a colleague
MYLAN SPECIALTY L.P. v. AUROBINDO PHARMA USA INC. (D.N.J. 2018)
| Docket | 3:18-cv-15190 | Date Filed | 2018-10-22 |
| Court | District Court, D. New Jersey | Date Terminated | 2019-08-29 |
| Cause | 35:271 Patent Infringement | Assigned To | Freda L. Wolfson |
| Jury Demand | None | Referred To | Lois H. Goodman |
| Patents | 6,702,997 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in MYLAN SPECIALTY L.P. v. AUROBINDO PHARMA USA INC.
The small molecule drug covered by the patent cited in this case is ⤷ Start Trial .
Details for MYLAN SPECIALTY L.P. v. AUROBINDO PHARMA USA INC. (D.N.J. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-10-22 | External link to document | |||
| 2018-10-22 | 1 | of United States Patent No. 6,702,997 (“the ’997 patent”) arising under the Patent Laws of the United… INFRINGEMENT OF U.S. PATENT NO. 6,702,997 31. Mylan repeats and realleges… THE PATENT-IN-SUIT 7. The ’997 patent, titled “Albuterol inhalation…forth in greater detail in the ’997 patent, the claims of the ’997 patent, incorporated by reference herein…claims of the ’997 patent, including without limitation claim 1 of the ’997 patent. 29. A | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
